Larvol Delta - Complete-remission-of-a-therapyrefractory-Kaposi39s-sarcoma-under-offlabel-therapy-with-ipilimumab-and-nivolumab

brenetafusp (IMC-F106C) - Immunocore

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

https://programme.conventus.de/ado-2026/program/program-points/badb1b91-fb45-4579-89cb-18aa65fd6d8a

Dr. Henriette Kirsten

Sep 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next